XML 23 R12.htm IDEA: XBRL DOCUMENT v3.21.1
Note 6 - Commitments and Contingencies
3 Months Ended
Mar. 31, 2021
Notes to Financial Statements  
Commitments and Contingencies Disclosure [Text Block]
Note
6.
Commitments and Contingencies
 
Contingencies —
Prior to
2016,
the Company originated, purchased, securitized, sold, invested in and serviced residential nonconforming mortgage loans and mortgage securities. The Company has received indemnification and loan repurchase demands with respect to alleged violations of representations and warranties (“defects”) and with respect to other alleged misrepresentations and contractual commitments made in loan sale and securitization agreements. These demands have been received substantially beginning in
2006
and have continued into recent years. Prior to the Company ceasing the origination of loans in its mortgage lending business, it sold loans to securitization trusts and other
third
parties and agreed to repurchase loans with material defects and to otherwise indemnify parties to these transactions. Beginning in
1997
and ending in
2007,
affiliates of the Company sold loans to securitization trusts and
third
parties with the potential of such obligations. The aggregate original principal balance of these loans was
$43.1
billion at the time of sale or securitization. The remaining principal balance of these loans is
not
available as these loans are serviced by
third
parties and
may
have been refinanced, sold or liquidated. Claims to repurchase loans or to indemnify under securitization documents have
not
been acknowledged as valid by the Company. In some cases, claims were made against affiliates of the Company that have ceased operations and have
no
or limited assets. The Company has
not
repurchased any loans or made any such indemnification payments since
2010.
 
Historically, repurchases of loans or indemnification of losses where a loan defect has been alleged have been insignificant and any future losses for alleged loan defects have
not
been deemed to be probable or reasonably estimable; therefore, the Company has recorded
no
reserves related to these claims. The Company does
not
use internal groupings for purposes of determining the status of these loans. The Company is unable to develop an estimate of the maximum potential amount of future payments related to repurchase demands because the Company does
not
have access to information relating to loans sold and securitized and the number or amount of claims deemed probable of assertion is
not
known nor is it reasonably estimated. Further, the validity of claims received remains questionable. Also, considering that the Company completed its last sale or securitization of loans during
2007,
the Company believes that it will be difficult for a claimant to successfully validate any additional repurchase demands. Management does
not
expect that the potential impact of claims will be material to the condensed consolidated financial statements.
 
 
 
Pending Litigation —
The Company is a party to various legal proceedings. Except as set forth below, these proceedings are of an ordinary and routine nature. Any legal fees associated with these proceedings are expensed as incurred.
 
Although it is
not
possible to predict the outcome of any legal proceeding, in the opinion of management, other than the active proceedings described in detail below, proceedings and actions against the Company should
not,
individually, or in the aggregate, have a material effect on the Company's financial condition, operations and liquidity. Furthermore, due to the uncertainty of any potential loss as a result of pending litigation and due to the Company's belief that an adverse ruling is
not
probable, the Company has
not
accrued a loss contingency related to the following matters in its condensed consolidated financial statements. However, a material outcome in
one
or more of the active proceedings described below could have a material impact on the results of operations in a particular quarter or fiscal year. 
 
On
May 21, 2008,
a purported class action case was filed in the Supreme Court of the State of New York, New York County, by the New Jersey Carpenters' Health Fund, on behalf of itself and all others similarly situated. Defendants in the case included NovaStar Mortgage Funding Corporation (“NMFC”) and NovaStar Mortgage, Inc. ("NMI"), wholly-owned subsidiaries of the Company, and NMFC's individual directors, several securitization trusts sponsored by the Company (“affiliated defendants”) and several unaffiliated investment banks and credit rating agencies. The case was removed to the United States District Court for the Southern District of New York. On
June 16, 2009,
plaintiff filed an amended complaint. Plaintiff seeks monetary damages, alleging that the defendants violated Sections
11,
12
and
15
of the Securities Act of
1933,
as amended, by making allegedly false statements regarding mortgage loans that served as collateral for securities purchased by plaintiff and the purported class members. On
August 31, 2009,
the Company filed a motion to dismiss the plaintiff's claims, which the court granted on
March 31, 2011,
with leave to amend. Plaintiff filed a
second
amended complaint on
May 16, 2011,
and the Company again filed a motion to dismiss. On
March 29, 2012,
the court dismissed plaintiff's
second
amended complaint with prejudice and without leave to replead. Plaintiff filed an appeal in the United States Court of Appeals for the Second Circuit (the "Appellate Court"). On
March 1, 2013,
the Appellate Court reversed the judgment of the lower court, which had dismissed the case. Also, the Appellate Court vacated the judgment of the lower court which had held that plaintiff lacked standing, even as a class representative, to sue on behalf of investors in securities in which plaintiff had
not
invested, and the appellate court remanded the case back to the lower court for further proceedings. On
April 23, 2013
plaintiff filed its memorandum with the lower court seeking a reconsideration of the earlier dismissal of plaintiff's claims as to
five
offerings in which plaintiff was
not
invested, and on
February 5, 2015,
the lower court granted plaintiff's motion for reconsideration and vacated its earlier dismissal. On
March 8, 2017,
the affiliated defendants and all other parties executed an agreement to settle the action, with the contribution of the affiliated defendants to the settlement fund being paid by their insurance carriers. The court certified a settlement class and granted preliminary approval to the settlement on
May 10, 2017. 
One member of the settlement class objected to the settlement and sought a stay of the final settlement approval hearing on the ground that it did
not
receive notice of the settlement and had
no
opportunity to timely opt out of the class.  After the court rejected the motion for a stay, the objector filed an appeal and requested a stay of the district court proceedings pending disposition of the appeal. The court of appeals denied the temporary stay of the district court proceedings and on
October 19, 2018
dismissed the appeal as moot.  Following the court of appeals' denial of the objector's petition for rehearing, the district court on
March 7, 2019
held a fairness hearing. On
March 8, 2019,
the district court issued a memorandum and order approving the settlement as fair, reasonable and adequate, and dismissing the action with prejudice.  Following entry of judgment, the objector filed a notice of appeal on
March 26, 2019,
and their opening brief was filed on
June 28, 2019.
The defendants answered on
September 27, 2019,
and the objector replied on
October 18, 2019.
Oral argument was held on
February 19, 2020.
Assuming the settlement approval becomes final, which is expected, the Company will incur
no
loss.  The Company believes that the affiliated defendants have meritorious defenses to the case and, if the settlement approval does
not
become final, expects them to defend the case vigorously.